Daito Pharmaceutical Co.,Ltd.
Simbol: 4577.T
JPX
2540
JPYTržna cena danes
12.0844
Razmerje P/E
-0.4769
Razmerje PEG
39.73B
Kapaciteta MRK
- 0.02%
Donos DIV
Daito Pharmaceutical Co.,Ltd. (4577-T) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 3607 | 4381 | 3372.9 | |||||||||||||||
balance-sheet.row.short-term-investments | 0 | -205 | -206 | -294.2 | |||||||||||||||
balance-sheet.row.net-receivables | 0 | 10670 | 10585 | 8382 | |||||||||||||||
balance-sheet.row.inventory | 0 | 18238 | 16820 | 15751.7 | |||||||||||||||
balance-sheet.row.other-current-assets | 0 | 8148 | 6123 | 4923.3 | |||||||||||||||
balance-sheet.row.total-current-assets | 0 | 40663 | 37909 | 32429.9 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 25837 | 23116 | 21372 | |||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.intangible-assets | 0 | 377 | 386 | 332.7 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 377 | 386 | 332.7 | |||||||||||||||
balance-sheet.row.long-term-investments | 0 | 3169 | 2958 | 3096 | |||||||||||||||
balance-sheet.row.tax-assets | 0 | 504 | 570 | 508 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | -1 | 0.7 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 29887 | 27029 | 25309.5 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 2 | 1 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 0 | 70552 | 64939 | 57739.4 | |||||||||||||||
balance-sheet.row.account-payables | 0 | 4435 | 4493 | 4359.6 | |||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1513 | 1200 | 1375.1 | |||||||||||||||
balance-sheet.row.tax-payables | 0 | 559 | 1402 | 1098.5 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 3445 | 2247 | 2018.9 | |||||||||||||||
Deferred Revenue Non Current | 0 | 507 | 755 | 764.3 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 0 | 4101 | 3887 | 3399.9 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 4153 | 3199 | 2963.2 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 92 | 0 | 1.5 | |||||||||||||||
balance-sheet.row.total-liab | 0 | 19581 | 17268 | 15822 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 49141 | 46273 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 0 | 7186 | 7031 | 6271.2 | |||||||||||||||
balance-sheet.row.retained-earnings | 0 | 35006 | 32338 | 28331.6 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 1531 | 1031 | 872.4 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -42192 | -39369 | 6143.7 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 50672 | 47304 | 41619 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 70552 | 64939 | 57739.4 | |||||||||||||||
balance-sheet.row.minority-interest | 0 | 299 | 367 | 298.4 | |||||||||||||||
balance-sheet.row.total-equity | 0 | 50971 | 47671 | 41917.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||
Total Investments | 0 | 2964 | 2752 | 2801.8 | |||||||||||||||
balance-sheet.row.total-debt | 0 | 4958 | 3447 | 3394 | |||||||||||||||
balance-sheet.row.net-debt | 0 | 1351 | -934 | 21.1 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 5076 | 6720 | 5873.9 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 3870 | 3313 | 3154.3 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -2326 | -4399 | -1582.4 | |||||||||||||||
cash-flows.row.account-receivables | 0 | -1502 | -3299 | 2723 | |||||||||||||||
cash-flows.row.inventory | 0 | -1413 | -1041 | -3609.2 | |||||||||||||||
cash-flows.row.account-payables | 0 | 538 | 22 | -765.1 | |||||||||||||||
cash-flows.row.other-working-capital | 0 | 51 | -81 | 69 | |||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -2465 | -1264 | -2263.3 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -5556 | -4733 | -6349.6 | |||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 68 | 0 | |||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -68 | 0 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 256 | 5 | |||||||||||||||
cash-flows.row.other-investing-activites | 0 | -10 | 77 | 20.3 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -5566 | -4400 | -6324.3 | |||||||||||||||
cash-flows.row.debt-repayment | 0 | -1638 | -1444 | -1712.4 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 308 | 1514 | 1798.5 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -116 | 1499 | -0.3 | |||||||||||||||
cash-flows.row.dividends-paid | 0 | -931 | -660 | -658.1 | |||||||||||||||
cash-flows.row.other-financing-activites | 0 | 2993 | 80 | 1997 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 616 | 989 | 1424.8 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 20 | 48 | 5.8 | |||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -774 | 1009 | 288.8 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 3607 | 4381 | 3372.9 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 4381 | 3372 | 3084.1 | |||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 4155 | 4370 | 5182.5 | |||||||||||||||
cash-flows.row.capital-expenditure | 0 | -5556 | -4733 | -6349.6 | |||||||||||||||
cash-flows.row.free-cash-flow | 0 | -1401 | -363 | -1167 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 45101 | 43464 | 48709.2 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 34770 | 32005 | 37917.3 | |||||||||||||||
income-statement-row.row.gross-profit | 0 | 10331 | 11459 | 10791.9 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | 0 | 3 | 37 | 28.4 | |||||||||||||||
income-statement-row.row.operating-expenses | 0 | 5123 | 4905 | 4883.1 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 39893 | 36910 | 42800.3 | |||||||||||||||
income-statement-row.row.interest-income | 0 | 45 | 46 | 0.4 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 12 | 9 | 7.8 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -135 | 152 | -43 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 3 | 37 | 28.4 | |||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -135 | 152 | -43 | |||||||||||||||
income-statement-row.row.interest-expense | 0 | 12 | 9 | 7.8 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 3870 | 3313 | 3154.3 | |||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 0 | 5207 | 6553 | 5908.8 | |||||||||||||||
income-statement-row.row.income-before-tax | 0 | 5076 | 6720 | 5873.9 | |||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 1549 | 2092 | 1716.9 | |||||||||||||||
income-statement-row.row.net-income | 0 | 3600 | 4668 | 4246 |
Pogosto zastavljeno vprašanje
Kaj je Daito Pharmaceutical Co.,Ltd. (4577.T) skupna sredstva?
Daito Pharmaceutical Co.,Ltd. (4577.T) skupna sredstva so 70552000000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.214.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 346.005.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.073.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.093.
Kaj je Daito Pharmaceutical Co.,Ltd. (4577.T) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 3600000000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 4958000000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 5123000000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.